Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ZYUS Life Sciences ( (TSE:ZYUS) ) just unveiled an update.
ZYUS Life Sciences Corporation, through its wholly-owned subsidiary ZYUS Life Sciences Inc., has entered into a loan agreement with Wayne Brownlee, who has advanced $1.5 million to the company. In return, ZYUS has agreed to issue 2,173,913 warrants to Brownlee as a loan bonus, pending approval from the TSX Venture Exchange. This transaction will increase Brownlee’s stake in the company to 13.87% on a partially diluted basis, reflecting a 2.36% increase from his previous holdings. The move is intended for investment purposes, and Brownlee may adjust his holdings based on market conditions and the company’s prospects.
The most recent analyst rating on (TSE:ZYUS) stock is a Buy with a C$1.50 price target. To see the full list of analyst forecasts on ZYUS Life Sciences stock, see the TSE:ZYUS Stock Forecast page.
More about ZYUS Life Sciences
Average Trading Volume: 11,213
Technical Sentiment Signal: Sell
Current Market Cap: C$46.67M
For detailed information about ZYUS stock, go to TipRanks’ Stock Analysis page.